Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pacific Biosciences of California

1.56
+0.01941.26%
Volume:2.26M
Turnover:3.54M
Market Cap:467.95M
PE:-0.67
High:1.60
Open:1.55
Low:1.55
Close:1.54
Loading ...

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Analysts Just Slashed This Year's Revenue Estimates By 14%

Simply Wall St.
·
22 Feb

PacBio to Participate in TD Cowen's 45th Annual Health Care Conference

GlobeNewswire
·
20 Feb

Pacific Biosciences Is Maintained at Neutral by Goldman Sachs

Dow Jones
·
19 Feb

Stock Track | Pacific Biosciences Soars 8.04% on Tuesday Following Analyst Price Target Updates

Stock Track
·
18 Feb

Unusually active option classes on open February 18th

TIPRANKS
·
18 Feb

Pacific Biosciences Price Target Maintained With a $2.50/Share by Stephens & Co.

Dow Jones
·
18 Feb

Morgan Stanley Sticks to Its Hold Rating for Pacific Biosciences (PACB)

TIPRANKS
·
18 Feb

PacBio grants equity incentive award to new employee

TIPRANKS
·
17 Feb

Pacific Biosciences of California Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.
·
15 Feb

PacBio Grants Equity Incentive Award to New Employee

GlobeNewswire
·
15 Feb

Genetics Tools Face Fund Cuts -- Barron's

Dow Jones
·
15 Feb

SoftBank reports new stakes in PacBio, Recursion Pharmaceuticals

TIPRANKS
·
15 Feb

PACB Stock Down Following In-Line Q4 Earnings, Revio Shipments Fall

Zacks
·
15 Feb

PacBio should return to growth over time, says Canaccord

TIPRANKS
·
15 Feb

BUZZ-Pacific Biosciences falls on Q4 revenue miss

Reuters
·
14 Feb

UBS Adjusts Price Target on Pacific Biosciences of California to $1.50 From $2, Keeps Neutral Rating

MT Newswires Live
·
14 Feb

Pacific Biosciences of California Inc (PACB) Q4 2024 Earnings Call Highlights: Navigating ...

GuruFocus.com
·
14 Feb

Pacific Biosciences of California (PACB) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
14 Feb

PacBio (NASDAQ:PACB) Misses Q4 Sales Targets

StockStory
·
14 Feb

Pacific Biosciences of California Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
14 Feb